ZTALMY: payments to doctors
Payments that named ZTALMY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $400K
- Providers
- 1,079
- Transactions
- 2,696
- Average per transaction
- $148
The per-transaction average — $148 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,079 providers the average total is $370, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Marinus Pharmaceuticals, Inc. | $394,337 | 98.7% |
| Immedica Pharma US, Inc. | $5,213 | 1.3% |